How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
72
TRVI Quote, Financials, Valuation and Earnings
Last price:
$6.27
Seasonality move
:
25.18%
Day range:
$6.36 - $6.68
52-week range:
$2.30 - $7.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.31x
Volume:
944.5K
Avg. volume:
3.4M
1-year change:
88.41%
Market cap:
$628.4M
Revenue:
--
EPS (TTM):
-$0.47
TRVI Analysts' Consensus Rating
The 7 analysts providing 12-month price projections for Trevi Therapeutics shares anticipate an average target of $19.83, ranging from a low estimate of $11.00 to a high estimate of $29.00. This average target implies a growth of 205.13% compared to the current stock price of $6.50.
Consensus Price Target
$19.83
Highest Price Target
$29.00
Lowest Price Target
$11.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 6 | 6 | 7 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
TRVI Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 31
Ajinomoto [AJINY] is down 2.15% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
69
AGX alert for Mar 31
Argan [AGX] is down 4.98% over the past day.
